Acadia Healthcare (NASDAQ:ACHC) Stock Rating Lowered by StockNews.com

Acadia Healthcare (NASDAQ:ACHC) was downgraded by equities research analysts at StockNews.com from a “hold” rating to a “sell” rating in a note issued to investors on Tuesday.

A number of other research analysts have also commented on ACHC. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $90.00 price objective on shares of Acadia Healthcare in a research report on Tuesday, March 5th. UBS Group raised their price objective on Acadia Healthcare from $88.00 to $102.00 and gave the stock a “buy” rating in a research report on Wednesday, February 28th. Barclays lowered their price objective on Acadia Healthcare from $91.00 to $89.00 and set an “overweight” rating on the stock in a research report on Wednesday, May 15th. Deutsche Bank Aktiengesellschaft raised Acadia Healthcare from a “sell” rating to a “hold” rating and set a $70.00 target price for the company in a research report on Thursday, April 25th. Finally, Mizuho lowered their price target on shares of Acadia Healthcare from $84.00 to $70.00 and set a “neutral” rating on the stock in a report on Friday, May 3rd. One analyst has rated the stock with a sell rating, three have issued a hold rating and six have assigned a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $87.56.

Acadia Healthcare Trading Up 1.4 %

Acadia Healthcare stock opened at $66.27 on Tuesday. Acadia Healthcare has a 52 week low of $64.11 and a 52 week high of $87.77. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.27 and a current ratio of 1.27. The firm has a market capitalization of $6.15 billion, a PE ratio of -473.32, a PEG ratio of 1.99 and a beta of 1.31. The business’s 50-day simple moving average is $72.83 and its 200-day simple moving average is $76.98.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings results on Thursday, May 2nd. The company reported $0.84 EPS for the quarter, topping analysts’ consensus estimates of $0.80 by $0.04. The company had revenue of $768.10 million during the quarter, compared to analyst estimates of $779.20 million. Acadia Healthcare had a positive return on equity of 11.49% and a negative net margin of 0.38%. The company’s quarterly revenue was up 9.1% compared to the same quarter last year. During the same period in the previous year, the company earned $0.75 earnings per share. Equities research analysts forecast that Acadia Healthcare will post 3.53 earnings per share for the current year.

Insider Buying and Selling

In other news, Director Wade D. Miquelon sold 2,203 shares of the business’s stock in a transaction that occurred on Tuesday, March 5th. The stock was sold at an average price of $85.39, for a total value of $188,114.17. Following the transaction, the director now directly owns 46,074 shares of the company’s stock, valued at approximately $3,934,258.86. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 2.00% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in ACHC. GAMMA Investing LLC bought a new position in shares of Acadia Healthcare in the fourth quarter worth about $26,000. Headlands Technologies LLC acquired a new position in Acadia Healthcare during the 3rd quarter worth $25,000. Mather Group LLC. bought a new position in Acadia Healthcare in the 1st quarter valued at $48,000. Fifth Third Bancorp increased its stake in shares of Acadia Healthcare by 25.5% in the 4th quarter. Fifth Third Bancorp now owns 670 shares of the company’s stock valued at $52,000 after buying an additional 136 shares during the period. Finally, DekaBank Deutsche Girozentrale acquired a new position in shares of Acadia Healthcare during the third quarter valued at $96,000.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.